Codexis (CDXS) Beats Q4 Earnings and Revenue Estimates

分组1 - Codexis reported quarterly earnings of $0.11 per share, exceeding the Zacks Consensus Estimate of $0.01 per share, compared to a loss of $0.13 per share a year ago, representing an earnings surprise of +2,100.00% [1] - The company posted revenues of $38.92 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.61%, and showing a significant increase from year-ago revenues of $21.46 million [2] - Codexis shares have declined approximately 23.9% since the beginning of the year, while the S&P 500 has only declined by 0.9% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $19.02 million, and for the current fiscal year, it is -$0.33 on revenues of $70.17 million [7] - The Medical - Biomedical and Genetics industry, to which Codexis belongs, is currently ranked in the bottom 42% of over 250 Zacks industries, indicating potential challenges for stock performance [8]